Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)
Go back to Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.86 +0.04 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $16.89 | |||
| Open | $3.77 | 52 Week Low | $7.35 | |||
| Day High | $3.92 | P/E | N/A | |||
| Day Low | $3.76 | EPS | $-2.35 | |||
| Volume | 1,432,106 | |||||
